Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061424PMC
http://dx.doi.org/10.1093/ckj/sfac180DOI Listing

Publication Analysis

Top Keywords

pseudo-acute kidney
4
kidney injury
4
injury secondary
4
secondary tepotinib
4
pseudo-acute
1
injury
1
secondary
1
tepotinib
1

Similar Publications

Article Synopsis
  • * Initial thoughts about her condition pointed to improper regulation of water in the body, but further investigation indicated that her symptoms might be due to poor fluid intake and a misdiagnosed kidney issue.
  • * The patient's liver enzyme levels improved with supportive treatment, allowing for the use of remdesivir, and her sodium levels gradually stabilized, underscoring the need for tailored patient management during COVID-19 recovery.
View Article and Find Full Text PDF
Article Synopsis
  • A study was done looking at reports about Capmatinib, a medicine, to find out if it causes any side effects (called AEs) that doctors should know about.
  • They checked a lot of data from the FDA from 2020 to 2023 and found over 1,900 reports related to Capmatinib, identifying some serious side effects not listed on the medicine's label.
  • The researchers want doctors to pay special attention to problems with kidneys and ear disorders when people are taking Capmatinib to keep patients safe.
View Article and Find Full Text PDF

Various classes of targeted therapies have emerged in the last few years, which have revolutionized cancer treatment, and improved the prognosis and survival of cancer patients. Unfortunately, these agents have serious toxic effects on the kidneys. Some of the toxic effects are hypertension, acute kidney injury (AKI), and proteinuria.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!